Sigyn Therapeutics Reports Second Quarter 2023 Financial Results

August 14, 2023

SAN DIEGO, CA, Aug. 14, 2023 (GLOBE NEWSWIRE) — Sigyn Therapeutics, Inc. (“Sigyn” or the “Company”) (OTCQB:SIGY), a medical technology company that creates blood purification devices to overcome clearly defined limitations in healthcare, today announces financial results for the second quarter ended June 30, 2023.

Read more at globenewswire.com

Related news for (SIGY)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.